Graypoint LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$985K Buy
3,574
+459
+15% +$125K 0.06% 215
2025
Q1
$826K Buy
3,115
+238
+8% +$58.7K 0.05% 230
2024
Q4
$668K Buy
2,877
+359
+14% +$82.6K 0.04% 250
2024
Q3
$556K Sell
2,518
-58
-2% -$12K 0.04% 286
2024
Q2
$506K Sell
2,576
-147
-5% -$30.4K 0.04% 272
2024
Q1
$586K Buy
2,723
+57
+2% +$12K 0.04% 248
2023
Q4
$561K Buy
2,666
+526
+25% +$112K 0.05% 242
2023
Q3
$428K Buy
2,140
+203
+10% +$40.4K 0.04% 263
2023
Q2
$359K Buy
1,937
+23
+1% +$4.25K 0.04% 269
2023
Q1
$366K Buy
+1,914
New +$346K 0.04% 250
2022
Q4
Sell
-1,231
Closed -$218K 337
2022
Q3
$218K Buy
+1,231
New +$243K 0.03% 299

Other funds holding CME

Graypoint LLC's CME Position: Q2 2025 in Review

Graypoint LLC increased its CME Group (CME) stake by 15% in Q2 2025, buying an estimated $125K and bringing the position to 3,574 shares worth $985K. The position accounts for 0.06% of the portfolio, ranked #215.

Graypoint LLC first reported a position in CME in Q3 2022 and has held it in 11 quarters since. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • Graypoint LLC held 3,574 shares of CME Group worth $985K as of Q2 2025.
  • Graypoint LLC bought 459 CME Group shares in Q2 2025, an estimated $125K.
  • CME Group made up 0.06% of Graypoint LLC's portfolio in Q2 2025, its #215 holding.
  • Graypoint LLC first reported a position in CME Group in Q3 2022 and has held it in 11 quarters since.
  • 1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.